Venturis Therapeutics

Share on: 

Venturis Therapeutics (formerly Cardiovascular Biotherapeutics) is a clinical stage biopharmaceutical company advancing novel therapeutics to address diseases such as diabetic wounds, severe ischemic heart disease and peripheral artery disease. They employ human proteins from the Fibroblast Growth Factor family. Their lead candidate stimulates the growth of new blood vessels when administered to ischemic organs and tissues.

Dallas TX
United States